Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder?

Kinjo, Manami; Masuda, Kazuki; Nakamura, Yu; Taguchi, Satoru; Tambo, Mitsuhiro; Fukuhara, Hiroshi

Kinjo, Manami; Masuda, Kazuki; Nakamura, Yu; Taguchi, Satoru; Tambo, Mitsuhiro; Fukuhara, Hiroshi.

Afiliação

Kinjo M; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo, 181-8611, Japan. Kinjo_1702@yahoo.co.jp.
Masuda K; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo, 181-8611, Japan.
Nakamura Y; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo, 181-8611, Japan.
Taguchi S; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo, 181-8611, Japan.
Tambo M; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo, 181-8611, Japan.
Fukuhara H; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, Tokyo, 181-8611, Japan.

Int Urogynecol J ; 34(4): 853-859, 2023 04.

Article em En | MEDLINE | ID: mdl-35699775

Assuntos

Síndrome Metabólica; Bexiga Urinária Hiperativa; Agentes Urológicos; Feminino; Humanos; Acetanilidas/uso terapêutico; Síndrome Metabólica/complicações; Resultado do Tratamento; Bexiga Urinária Hiperativa/complicações; Bexiga Urinária Hiperativa/tratamento farmacológico; Bexiga Urinária Hiperativa/diagnóstico; Agentes Urológicos/uso terapêutico

Palavras-chave

Metabolic syndrome; Mirabegron; Overactive bladder; Treatment efficacy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Bexiga Urinária Hiperativa / Agentes Urológicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google